Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients.

@article{Fairhead2012PoorSB,
  title={Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients.},
  author={Todd Fairhead and Elizabeth Hendren and Kathryn J Tinckam and Caren Rose and Chris H Sherlock and Liping Shi and Natasha Sarah Crowcroft and Jonathan B. Gubbay and David Landsberg and G. Knoll and Jagbir Singh Gill and Deepali Kumar},
  journal={Transplant infectious disease : an official journal of the Transplantation Society},
  year={2012},
  volume={14 6},
  pages={575-83}
}
BACKGROUND Seasonal and pandemic influenza virus infections in renal transplant patients are associated with poor outcomes. During the pandemic of 2009-2010, the AS03-adjuvanted monovalent H1N1 influenza vaccine was recommended for transplant recipients, although its immunogenicity in this population was unknown. We sought to determine the safety and immunogenicity of an adjuvant-containing vaccine against pandemic influenza A H1N1 2009 (pH1N1) administered to kidney transplant recipients… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 37 references

Immune response to an adjuvanted influenzaAH 1 N 1 vaccine ( Pandemrix ( R ) ) in renal transplant recipients

  • S Brakemeier, B Schweiger, N Lachmann
  • Nephrol Dial Transplant
  • 2011

Similar Papers

Loading similar papers…